Critical Analysis: Reliv’ International (RELV) & Its Peers

Institutional & Insider Ownership

7.8% of Reliv’ International shares are owned by institutional investors. Comparatively, 31.6% of shares of all “Pharmaceutical Preparations” companies are owned by institutional investors. 30.0% of Reliv’ International shares are owned by company insiders. Comparatively, 14.8% of shares of all “Pharmaceutical Preparations” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

Reliv’ International has a beta of -0.04, indicating that its share price is 104% less volatile than the S&P 500. Comparatively, Reliv’ International’s competitors have a beta of 12.21, indicating that their average share price is 1,121% more volatile than the S&P 500.

Earnings and Valuation

This table compares Reliv’ International and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Reliv’ International	$35.06 million	-$440,000.00	-22.22
Reliv’ International Competitors	$332.57 million	-$25.10 million	-4.45

Reliv’ International’s competitors have higher revenue, but lower earnings than Reliv’ International. Reliv’ International is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Reliv’ International and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Reliv’ International	-0.61%	-1.89%	-1.31%
Reliv’ International Competitors	-5,512.31%	-257.15%	-49.07%

Dividends

Reliv’ International pays an annual dividend of $0.02 per share and has a dividend yield of 1.0%. Reliv’ International pays out -22.2% of its earnings in the form of a dividend. As a group, “Pharmaceutical Preparations” companies pay a dividend yield of 16.8% and pay out 218.1% of their earnings in the form of a dividend.

Summary

Reliv’ International beats its competitors on 6 of the 11 factors compared.

Reliv’ International Company Profile

Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.